BioMall
Brand Store/BDB Bioscience/BD PharmingenTM PE-CyTM7 Rat Anti-Mouse TNF
BD PharmingenTM PE-CyTM7 Rat Anti-Mouse TNF
GENERAL CATALOGUE

BD PharmingenTM PE-CyTM7 Rat Anti-Mouse TNF

561041 · 25 ug

BDB Bioscience · Cat: 561041

₹140 – ₹200 approx.This price excludes freight and taxes. Please RFQ to get the final price.

Reach 3+ verified distributors

Catalog No: 561041
Category: reagents
Pack Size: 25 ug
Brand: BDB Bioscience

Description

Expression of TNF by stimulated CD4+ and CD4- BALB/c spleen cells. Splenocytes from BALB/c mice were stimulated for 4 hours with PMA 5 ng/ml, Sigma, P-8139 and Ionomycin 500 ng, Sigma I-0634 in the presence of Brefeldin A GolgiPlug, Cat. No. 555029 . Cells were harvested, fixed, permeabilized and stained with APC-conjugated rat anti-mouse CD4 APC-RM4-5, Cat. No. 553051 and either rat anti-mouse TNF antibody PE-Cy7-MP6-XT22, Cat. No. 557644 left panel or immunoglobulin isotype control PE-Cy7-R3-34, Cat. No. 557645 , right panel by using BD Pharmingen staining protocol. To demonstrate specificity of staining the binding of PE-Cy7-MP6-XT22 was blocked by the preincubation of the conjugated antibody with molar excess of recombinant mouse TNF 0.25 mug, Cat. No. 554589, data not shown and by preincubation of the fixed/permeabilized cells with an excess of unlabelled MP6-XT22 antibody 5 mug, Cat. No. 554416, data not shown prior to staining. The quadrant markers for the bivariate dot plots were set based on the autofluorescence and isotype controls. Expression of TNF by stimulated CD4+ and CD4- BALB/c spleen cells. Splenocytes from BALB/c mice were stimulated for 4 hours with PMA 5 ng/ml, Sigma, P-8139 and Ionomycin 500 ng, Sigma I-0634 in the presence of Brefeldin A GolgiPlug, Cat. No. 555029 . Cells were harvested, fixed, permeabilized and stained with APC-conjugated rat anti-mouse CD4 APC-RM4-5, Cat. No. 553051 and either rat anti-mouse TNF antibody PE-Cy7-MP6-XT22, Cat. No. 557644 left panel or immunoglobulin isotype control PE-Cy7-R3-34, Cat. No. 557645 , right panel by using BD Pharmingen staining protocol. To demonstrate specificity of staining the binding of PE-Cy7-MP6-XT22 was blocked by the preincubation of the conjugated antibody with molar excess of recombinant mouse TNF 0.25 mug, Cat. No. 554589, data not shown and by preincubation of the fixed/permeabilized cells with an excess of unlabelled MP6-XT22 antibody 5 mug, Cat. No. 554416, data not shown prior to staining. The quadrant markers for the bivariate dot plots were set based on the autofluorescence and isotype controls. Expression of TNF by stimulated CD4+ and CD4- BALB/c spleen cells. Splenocytes from BALB/c mice were stimulated for 4 hours with PMA 5 ng/ml, Sigma, P-8139 and Ionomycin 500 ng, Sigma I-0634 in the presence of Brefeldin A GolgiPlug, Cat. No. 555029 . Cells were harvested, fixed, permeabilized and stained with APC-conjugated rat anti-mouse CD4 APC-RM4-5, Cat. No. 553051 and either rat anti-mouse TNF antibody PE-Cy7-MP6-XT22, Cat. No. 557644 left panel or immunoglobulin isotype control PE-Cy7-R3-34, Cat. No. 557645 , right panel by using BD Pharmingen staining protocol. To demonstrate specificity of staining the binding of PE-Cy7-MP6-XT22 was blocked by the preincubation of the conjugated antibody with molar excess of recombinant mouse TNF 0.25 mug, Cat. No. 554589, data not shown and by preincubation of the fixed/permeabilized cells with an excess of unlabelled MP6-XT22 antibody 5 mug, Cat. No. 554416, data not shown prior to staining. The quadrant markers for the bivariate dot plots were set based on the autofluorescence and isotype controls. Show More Expression of TNF by stimulated CD4+ and CD4- BALB/c spleen cells. Splenocytes from BALB/c mice were stimulated for 4 hours with PMA 5 ng/ml, Sigma, P-8139 and Ionomycin 500 ng, Sigma I-0634 in the presence of Brefeldin A GolgiPlug, Cat. No. 555029 . Cells were harvested, fixed, permeabilized and stained with APC-conjugated rat anti-mouse CD4 APC-RM4-5, Cat. No. 553051 and either rat anti-mouse TNF antibody PE-Cy7-MP6-XT22, Cat. No. 557644 left panel or immunoglobulin isotype control PE-Cy7-R3-34, Cat. No. 557645 , right panel by using BD Pharmingen staining protocol. To demonstrate specificity of staining the binding of PE-Cy7-MP6-XT22 was blocked by the preincubation of the conjugated antibody with molar excess of recombinant mouse TNF 0.25 mug, Cat. No. 554589, data not shown and by preincubation of the fixed/permeabilized cells with an excess of unlabelled MP6-XT22 antibody 5 mug, Cat. No. 554416, data not shown prior to staining. The quadrant markers for the bivariate dot plots were set based on the autofluorescence and isotype controls. Show More Expression of TNF by stimulated CD4+ and CD4- BALB/c spleen cells. Splenocytes from BALB/c mice were stimulated for 4 hours with PMA 5 ng/ml, Sigma, P-8139 and Ionomycin 500 ng, Sigma I-0634 in the presence of Brefeldin A GolgiPlug, Cat. No. 555029 . Cells were harvested, fixed, permeabilized and stained with APC-conjugated rat anti-mouse CD4 APC-RM4-5, Cat. No. 553051 and either rat anti-mouse TNF antibody PE-Cy7-MP6-XT22, Cat. No. 557644 left panel or immunoglobulin isotype control PE-Cy7-R3-34, Cat. No. 557645 , right panel by using BD Pharmingen staining protocol. To demonstrate specificity of staining the binding of PE-Cy7-MP6-XT22 was blocked by the preincubation of the conjugated antibody with molar excess of recombinant mouse TNF 0.25 mug, Cat. No. 554589, data not shown and by preincubation of the fixed/permeabilized cells with an excess of unlabelled MP6-XT22 antibody 5 mug, Cat. No. 554416, data not shown prior to staining. The quadrant markers for the bivariate dot plots were set based on the autofluorescence and isotype controls. Expression of TNF by stimulated CD4+ and CD4- BALB/c spleen cells. Splenocytes from BALB/c mice were stimulated for 4 hours with PMA 5 ng/ml, Sigma, P-8139 and Ionomycin 500 ng, Sigma I-0634 in the presence of Brefeldin A GolgiPlug, Cat. No. 555029 . Cells were harvested, fixed, permeabilized and stained with APC-conjugated rat anti-mouse CD4 APC-RM4-5, Cat. No. 553051 and either rat anti-mouse TNF antibody PE-Cy7-MP6-XT22, Cat. No. 557644 left panel or immunoglobulin isotype control PE-Cy7-R3-34, Cat. No. 557645 , right panel by using BD Pharmingen staining protocol. To demonstrate specificity of staining the binding of PE-Cy7-MP6-XT22 was blocked by the preincubation of the conjugated antibody with molar excess of recombinant mouse TNF 0.25 mug, Cat. No. 554589, data not shown and by preincubation of the fixed/permeabilized cells with an excess of unlabelled MP6-XT22 antibody 5 mug, Cat. No. 554416, data not shown prior to staining. The quadrant markers for the bivariate dot plots were set based on the autofluorescence and isotype controls.

More from BDB Bioscience

BD HorizonTM BV421 Mouse Anti-Human TIGIT
BD HorizonTM BV421 Mouse Anti-Human TIGIT
570445
reagents
BD OptiBuildTM BV750 Mouse Anti-Human HLA-DQ
BD OptiBuildTM BV750 Mouse Anti-Human HLA-DQ
746968
reagents
BD OptiBuildTM BV750 Rat Anti-Mouse CD93 (Early B Lineage)
BD OptiBuildTM BV750 Rat Anti-Mouse CD93 (Early B Lineage)
746849
reagents
BD OptiBuildTM BV510 Rat Anti-Mouse Delta-Like Protein 1
BD OptiBuildTM BV510 Rat Anti-Mouse Delta-Like Protein 1
744997
reagents
BD OptiBuildTM BUV805 Mouse Anti-Human CD275
BD OptiBuildTM BUV805 Mouse Anti-Human CD275
748933
reagents
BD OptiBuildTM BV650 Rat Anti-Mouse CD23
BD OptiBuildTM BV650 Rat Anti-Mouse CD23
740456
reagents
BD OptiBuildTM R718 Rat Anti-Mouse CCRL2
BD OptiBuildTM R718 Rat Anti-Mouse CCRL2
752021
reagents
BD PharmingenTM Mouse B Lymphocyte Activation Antibody Cocktail, with Isotype Control; PE-CyTM7 CD25, PE CD69, & FITC CD19
BD PharmingenTM Mouse B Lymphocyte Activation Antibody Cocktail, with Isotype Control; PE-CyTM7 CD25, PE CD69, & FITC CD19
558064
reagents